➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
Moodys
McKesson
Boehringer Ingelheim
Harvard Business School

Last Updated: July 28, 2021

DrugPatentWatch Database Preview

TOPAMAX SPRINKLE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Topamax Sprinkle, and when can generic versions of Topamax Sprinkle launch?

Topamax Sprinkle is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in TOPAMAX SPRINKLE is topiramate. There are twenty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the topiramate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Topamax Sprinkle

A generic version of TOPAMAX SPRINKLE was approved as topiramate by ACCORD HLTHCARE on March 27th, 2009.

  Free Forever Trial

Drug patent expirations by year for TOPAMAX SPRINKLE
Drug Prices for TOPAMAX SPRINKLE

See drug prices for TOPAMAX SPRINKLE

Recent Clinical Trials for TOPAMAX SPRINKLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mylan PharmaceuticalsPhase 1
Teva Pharmaceuticals USAPhase 1

See all TOPAMAX SPRINKLE clinical trials

Paragraph IV (Patent) Challenges for TOPAMAX SPRINKLE
Tradename Dosage Ingredient NDA Submissiondate
TOPAMAX CAPSULE;ORAL topiramate 020844 2005-09-07
TOPAMAX SPRINKLE CAPSULE;ORAL topiramate 020844 2005-09-07

US Patents and Regulatory Information for TOPAMAX SPRINKLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms TOPAMAX SPRINKLE topiramate CAPSULE;ORAL 020844-003 Oct 26, 1998 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TOPAMAX SPRINKLE

International Patents for TOPAMAX SPRINKLE

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9944581 ⤷  Free Forever Trial
Turkey 200002541 ⤷  Free Forever Trial
Germany 69910186 ⤷  Free Forever Trial
Denmark 457784 ⤷  Free Forever Trial
Finland 843765 ⤷  Free Forever Trial
China 1419444 ⤷  Free Forever Trial
Canada 1241951 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for TOPAMAX SPRINKLE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0138441 SPC/GB95/028 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: TOPIRAMATE; REGISTERED: UK 0242/0301 19950718
0138441 97C0097 Belgium ⤷  Free Forever Trial PRODUCT NAME: TOPIRAMAAT; NAT. REGISTRATION NO/DATE: 1028 IS 71 F 3 19970616; FIRST REGISTRATION: GB PL/0242/0301 19950718
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Moodys
McKesson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.